17 December 2018
Article in SciLifeLab Synergy 2, 2018
Beactica's Head of Discovery, Dr Ulf Bremberg, explains how the company’s specialist small molecule drug discovery platform is developing a novel therapy for glioblastoma.
Read full article here.
See all recent coverage
Sign up for the Beactica newsletter to receive our latest news and updates